Atlantic Lithium Ltd (ALL)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 13.90 |
|---|---|
| 52-week range | 6.60 – 20.40 |
| Return, 1 month / 3 months | −12.0% / −9.7% |
| Return, 1 year / 3 years | +56.2% / −41.2% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 80.0% |
| Worst drawdown (1 year) | -41.4% |
| Average daily value traded | 18.51M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Atlantic Lithium is a mineral exploration and development company focused on lithium, based in Australia and operating in West Africa. Its main asset is the Ewoyaa lithium project in Ghana, where it is working to develop a hard rock lithium mine and processing operation. The company also explores for lithium and other minerals across its portfolio of tenements in Ghana and Ivory Coast. Its customers would be participants in the battery and electric vehicle supply chain that use lithium concentrates.
On this site Atlantic Lithium Ltd appears as a stock on the London Exchange (UK), code ALL, with prices in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Atlantic Lithium Ltd (ALL) trades on the London Exchange in UK. It last closed at GBX 13.90 on 23 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 2,537 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 56.2% and over the last three months it fell 9.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 33 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.5% | ||
| From 52-week high | -27.7% | ||
| Momentum | 50 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -9.7% | ||
| 6-month return | -11.5% | ||
| 12-month return, skipping the last month | 77.5% | ||
| Stability (higher is calmer) | 20 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 80.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.4% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 18.51M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +2.2% |
|---|---|
| 1 month | −12.0% |
| 3 months | −9.7% |
| 6 months | −11.5% |
| 1 year | +56.2% |
| 3 years | −41.2% |
| 5 years | −24.9% |
Signals
| 50-day / 200-day average | 14.72 / 15.19 |
|---|---|
| Golden / death cross (60 days) | Death, 10 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.61 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.